Search research articles
Contact Us
Filters
Showing results (71-80 of 329) with videos related to
Page
of 33
Sort By:
Physical Review. C, Nuclear Physics
|
April 1, 1988
Neutron-proton scattering observables at 325 MeV, the epsilon 1 parameter, and the tensor force
Chulick, Elster, Machleidt, et al.
Methods of Biochemical Analysis
|
January 1, 1980
Solid-phase methods in protein sequence analysis
R A Laursen, W Machleidt
FEBS Letters
|
June 30, 1997
A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase
C Randak, P Neth, E A Auerswald, et al.
FEBS Letters
|
August 12, 1996
Cyclodextrins as templates for the presentation of protease inhibitors
N Schaschke, H J Musiol, I Assfalg-Machleidt, et al.
Der Nervenarzt
|
August 10, 2004
[Coenaesthesia after infection with Varicella zoster virus. The psychodynamic meaning of suffering a children's disease at adult age]
B R Brüggemann, W Machleidt
Physical Review. C, Nuclear Physics
|
November 1, 1993
Relativistic microscopic description of proton-nucleus scattering at intermediate energies
Li, Machleidt, Fritz, et al.
MMW Fortschritte Der Medizin
|
November 9, 2007
[Immigrants in the general medical practice. Good patient-doctor-patient relationship protects against somatization]
W Machleidt, H J Assion
Biological Chemistry
|
July 11, 2002
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin
Norbert Schaschke, Dominga Deluca, Irmgard Assfalg-Machleidt, et al.
Biological Chemistry Hoppe-Seyler
|
October 1, 1988
Inhibitorily active recombinant human stefin B. Gene synthesis, expression and isolation of an inhibitory active MS-2 pol-stefin B fusion protein and preparation of Des[Met1,2(2)]stefin B
U Thiele, E A Auerswald, W Gebhard, et al.
Fortschritte Der Neurologie-Psychiatrie
|
January 5, 2008
[Socialpsychiatric and ethical reflections about prevention of schizophrenic disorders]
W Machleidt, B R Brüggemann
Page
of 33
Search research articles
Search
Showing results (71-80 of 329) with videos related to
Sort By:
Page
of 33
Physical Review. C, Nuclear Physics
|
April 1, 1988
Neutron-proton scattering observables at 325 MeV, the epsilon 1 parameter, and the tensor force
Chulick, Elster, Machleidt, et al.
Methods of Biochemical Analysis
|
January 1, 1980
Solid-phase methods in protein sequence analysis
R A Laursen, W Machleidt
FEBS Letters
|
June 30, 1997
A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase
C Randak, P Neth, E A Auerswald, et al.
FEBS Letters
|
August 12, 1996
Cyclodextrins as templates for the presentation of protease inhibitors
N Schaschke, H J Musiol, I Assfalg-Machleidt, et al.
Der Nervenarzt
|
August 10, 2004
[Coenaesthesia after infection with Varicella zoster virus. The psychodynamic meaning of suffering a children's disease at adult age]
B R Brüggemann, W Machleidt
Physical Review. C, Nuclear Physics
|
November 1, 1993
Relativistic microscopic description of proton-nucleus scattering at intermediate energies
Li, Machleidt, Fritz, et al.
MMW Fortschritte Der Medizin
|
November 9, 2007
[Immigrants in the general medical practice. Good patient-doctor-patient relationship protects against somatization]
W Machleidt, H J Assion
Biological Chemistry
|
July 11, 2002
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin
Norbert Schaschke, Dominga Deluca, Irmgard Assfalg-Machleidt, et al.
Biological Chemistry Hoppe-Seyler
|
October 1, 1988
Inhibitorily active recombinant human stefin B. Gene synthesis, expression and isolation of an inhibitory active MS-2 pol-stefin B fusion protein and preparation of Des[Met1,2(2)]stefin B
U Thiele, E A Auerswald, W Gebhard, et al.
Fortschritte Der Neurologie-Psychiatrie
|
January 5, 2008
[Socialpsychiatric and ethical reflections about prevention of schizophrenic disorders]
W Machleidt, B R Brüggemann
Page
of 33